Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

@article{Huang2011LongTermOW,
  title={Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder},
  author={Yu-Shu Huang and Ming-Horng Tsai},
  journal={CNS Drugs},
  year={2011},
  volume={25},
  pages={539-554}
}
Attention-deficit hyperactivity disorder (ADHD), a common neuro-behavioural disorder characterized by inattention, hyperactivity and impulsivity, is a chronic disorder and often persists into adulthood. CNS stimulants have been the most well known treatment for ADHD for several decades due to their high effectiveness, good safety profiles and relatively minor adverse effects. Non-stimulant agents, including atomoxetine, extended-release guanfacine and extended-release clonidine (US FDA approved… 
Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
TLDR
ADHD patients significantly improved in impulsivity and perceptual sensitivity, determined as TOVA, during MPH treatment for 12 months, and age and gender, yet not ADHD subtypes, appear to influence the MPH treatment effects in some indices of TOVA.
The Potential Role of Neuroendocrine in Patients with Attention-Deficit/Hyperactivity Disorder
TLDR
The neuroendocrine system, the activation of which is closely associated with age and gender, may influence developing neural circuitry and be‐ havioral systems; thus it has reasonably been speculated that this system plays a role in the pathogenesis of ADHD.
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
TLDR
The available findings in non-human primates support the notion that the administration of amphetamine and methylphenidate with procedures simulating clinical treatment conditions does not lead to long-term adverse effects in regard to development, neurobiology or behaviour as related to the central dopaminergic system.
ReviewAttention deficit hyperactivity disorderTrastorno por déficit de atención con hiperactividad
TLDR
Although multimodal treatment including both pharmacological and psychosocial interventions is usually recommended, no convincing evidence exists to support this recommendation, and Pharmacological treatment has fundamentally shown to improve ADHD symptoms in the short term.
Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
TLDR
Resveratrol administration for a duration of 8 weeks improved characteristic symptoms in patients with ADHD according to their parents and further investigations containing larger sample sizes, longer supplementation periods, and dose–response evaluations are required to replicate these findings in ADHD children more confidently.
Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
TLDR
Findings suggest that neurocognitive deficits in ADHD patients, except inhibition ability, might be long lasting in realistic settings.
Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review
TLDR
Research provides evidence that physical exercise represents a promising alternative or additional treatment option for patients with ADHD, and potential acute and chronic beneficial effects of especially cardio exercise were reported with regard to several cognitive, behavioral, and socio-emotional functions.
Attention-deficit hyperactivity disorder and cardiac vagal control: a systematic review
TLDR
A systematic review of three databases was conducted between January and March 2012 for peer reviewed publications examining the relationship between cardiac vagal control (CVC) and ADHD without comorbid psychopathology and suggested that children with unmedicated ADHD experienced lower levels of CVC than did healthy controls.
Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
TLDR
The results suggested that according to a longitudinal follow-up, behavioral and neuropsychological changes among patients with ADHD might differ between genders.
The Effects of a Traditional Chinese Medication on Children with Attention-Deficit/Hyperactivity Disorder.
TLDR
This particular TCM formula may prove to be a useful adjunctive treatment for children with ADHD, and randomized controlled trials need to be conducted to evaluate its efficacy.
...
1
2
3
4
...

References

SHOWING 1-10 OF 130 REFERENCES
Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms
Patients with attention-deficit hyperactivity disorder (ADHD) exhibit a wide range of symptoms related to functional impairment. Psychiatric comorbidities are highly prevalent among these patients,
Attention-deficit hyperactivity disorder
TLDR
Converging evidence from animal and human studies implicates the dysregulation of frontal-subcortical-cerebellar catecholaminergic circuits in the pathophysiology of ADHD, and molecular imaging studies suggest that abnormalities of the dopamine transporter lead to impaired neurotransmission.
Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
TLDR
Methylphenidate seems to offer the greatest and most immediate improvement of ADHD symptoms and does not seem to worsen tic symptoms, and alpha-2 agonists offer the best combined improvement in both tic and ADHD symptoms.
Stimulant Medication Withdrawal During Long-term Therapy in Children With Comorbid Attention-Deficit Hyperactivity Disorder and Chronic Multiple Tic Disorder
TLDR
Abrupt withdrawal of stimulant medication in children receiving long-term maintenance therapy does not appear to result in worsening of tic frequency or severity, and these findings do not preclude the possibility of drug withdrawal reactions in susceptible individuals.
Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder.
TLDR
Effectiveness for most subjects was maintained over long-term atomoxetine treatment, as demonstrated by total scores and total T scores on the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version.
Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
  • S. Wigal
  • Psychology, Medicine
    CNS Drugs
  • 2009
TLDR
Evaluating the efficacy and safety profiles of medications used for the management of ADHD suggests that the combination of behavioural and medical therapy may benefit most patients, and future research may provide an improved understanding of polypharmacy.
Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.
TLDR
The long-term treatment outcome shows that stimulants are effective in adult ADHD and side effects tend to be mild.
First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
TLDR
The results of high quality studies, in addition to specialized studies with methodological limitations, suggest that stimulants are the criterion standard for the safe and successful treatment of ADHD.
Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?
TLDR
It is suggested that stimulant therapy in childhood is associated with a reduction in the risk for subsequent drug and alcohol use disorders.
Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
TLDR
Long-term treatment with methylphenidate seems to be safe and effective for the management of ADHD behaviors in many (but not necessarily all) children with mild to moderate tic disorder.
...
1
2
3
4
5
...